Mrv1909 06132016512D 15 16 0 0 0 0 999 V2000 -0.1135 0.0671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6712 0.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3716 -0.7141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7812 0.5524 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.5713 -0.4043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2769 -0.2288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8397 1.1306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1942 -0.7141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.1136 -1.3818 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.4490 0.0671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6127 -1.2786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0616 0.0258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6210 1.3818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2337 0.3217 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.2337 0.8312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 0 0 0 0 1 4 1 0 0 0 0 1 5 1 0 0 0 0 2 6 2 0 0 0 0 2 7 1 0 0 0 0 3 8 1 0 0 0 0 3 9 2 0 0 0 0 4 10 1 0 0 0 0 5 11 1 0 0 0 0 6 12 1 0 0 0 0 7 13 2 0 0 0 0 10 14 2 0 0 0 0 12 15 2 0 0 0 0 8 10 1 0 0 0 0 13 15 1 0 0 0 0 M END > DBMET00056 > drugbank > CCC1(NC(=O)NC1=O)C1=CC=CC=C1 > InChI=1S/C11H12N2O2/c1-2-11(8-6-4-3-5-7-8)9(14)12-10(15)13-11/h3-7H,2H2,1H3,(H2,12,13,14,15) > UDTWZFJEMMUFLC-UHFFFAOYSA-N > C11H12N2O2 > 204.2252 > 204.089877638 > 2 > 27 > -0.01416402959483023 > 20.54958396891138 > 1 > 2 > 0 > 1 > 5-ethyl-5-phenylimidazolidine-2,4-dione > 1.53 > 1.4414972183333328 > -2.44 > 0 > 0 > 2 > 0 > 18.481275457718358 > 8.842617834888204 > -8.426584922403558 > 58.199999999999996 > 54.6413 > 2 > 1 > 7.38e-01 g/l > (2S,3S,4S,5R,6R)-6-[5-(4'-{[2-butyl-4-chloro-5-(hydroxymethyl)imidazol-1-yl]methyl}-[1,1'-biphenyl]-2-yl)-1,2,3,4-tetrazol-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid > 0 > DBMET00056 > Nirvanol > 631-07-2 > 23SM1FA1AK $$$$